Lipocine Balance Sheet Health

Financial Health criteria checks 6/6

Lipocine has a total shareholder equity of $19.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $20.7M and $1.6M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$19.82m
EquityUS$19.12m
Total liabilitiesUS$1.58m
Total assetsUS$20.70m

Recent financial health updates

Does Lipocine (NASDAQ:LPCN) Have A Healthy Balance Sheet?

Feb 22
Does Lipocine (NASDAQ:LPCN) Have A Healthy Balance Sheet?

Is Lipocine (NASDAQ:LPCN) Using Debt Sensibly?

Sep 14
Is Lipocine (NASDAQ:LPCN) Using Debt Sensibly?

Lipocine (NASDAQ:LPCN) Has Debt But No Earnings; Should You Worry?

Dec 04
Lipocine (NASDAQ:LPCN) Has Debt But No Earnings; Should You Worry?

Recent updates

Lipocine announces plans to focus on treating CNS disorders, shares rise ~5%

Sep 26

Does Lipocine (NASDAQ:LPCN) Have A Healthy Balance Sheet?

Feb 22
Does Lipocine (NASDAQ:LPCN) Have A Healthy Balance Sheet?

Is Lipocine (NASDAQ:LPCN) Using Debt Sensibly?

Sep 14
Is Lipocine (NASDAQ:LPCN) Using Debt Sensibly?

Lipocine soars 9% on FDA greenlight for Phase 2 LPCN 1154 study in postpartum depression

Jun 14

Lipocine competitor prevails in patent infringement lawsuit for Jatenzo

May 26

When Will Lipocine Inc. (NASDAQ:LPCN) Turn A Profit?

May 11
When Will Lipocine Inc. (NASDAQ:LPCN) Turn A Profit?

Lipocine EPS beats by $0.01

May 06

Lipocine Inc. (NASDAQ:LPCN): Are Analysts Optimistic?

Jan 26
Lipocine Inc. (NASDAQ:LPCN): Are Analysts Optimistic?

Lipocine announces positive results from phase 2biopsy-confirmed NASH study

Jan 12

FDA Ok's Lipocine's testosterone replacement therapy, tentatively

Dec 09

Lipocine (NASDAQ:LPCN) Has Debt But No Earnings; Should You Worry?

Dec 04
Lipocine (NASDAQ:LPCN) Has Debt But No Earnings; Should You Worry?

Lipocine EPS misses by $0.01

Nov 10

Lipocine: TLANDO Might Become A Potential TRT Option In Patients With COVID-19 Infection

Nov 06

Financial Position Analysis

Short Term Liabilities: LPCN's short term assets ($20.5M) exceed its short term liabilities ($1.6M).

Long Term Liabilities: LPCN has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: LPCN is debt free.

Reducing Debt: LPCN has no debt compared to 5 years ago when its debt to equity ratio was 105.7%.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: LPCN has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: LPCN has sufficient cash runway for 2.9 years if free cash flow continues to grow at historical rates of 10.3% each year.


Discover healthy companies